Report Description Report Description and Highlights

Global Cannabis Testing Market Research Report:

The latest report by IMARC, titled “ Cannabis Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023 -2028

” " the global cannabis testing market size reached US$ 1,269 Million in 2022. Cannabis testing refers to the process of analyzing cannabis products to determine their chemical composition, potency, and purity. It includes various tests for cannabinoids, heavy metals, residual solvents, pesticides, terpenes, and microbial contaminants. It is widely used for breeding and cultivation, medical research, consumer safety, product development, and quality control. Cannabis testing improves product transparency, ensures consistency, increases trust, and protects users from harmful substances and toxic chemicals. It is also a highly reliable and efficient process that helps manufacturers and researchers in developing advanced cannabis strains with improved flavor profiles and therapeutic benefits.

Request Free Sample Report: https://www.imarcgroup.com/cannabis-testing-market/requestsample

Global Cannabis Testing Market Trends :

The growing legalization of cannabis for recreational purposes across the globe is one of the primary factors driving the market growth. Cannabis testing plays a critical role in the manufacturing process to ensure the safety and purity of products, meet quality standards, and protect consumers from harmful chemicals, diseases, and various toxic metals, such as lead and cadmium. In addition to this, the rising number numbers of cannabis products, such as oils, edibles, capsules, concentrates, tinctures, topicals, and vape cartridges, is acting as another growth-inducing factor. Furthermore, the increasing adoption of cannabis in medical research to treat various conditions, such as chronic pain, anxiety, and epilepsy, is propelling the market growth. Additionally, the introduction of portable testing devices that use spectroscopy and chromatography to provide faster and more accurate results in real-time is positively influencing the market growth. Apart from this, the integration of next-generation sequencing (NGS) in testing methods to identify genetic markers and optimize breeding programs for developing desirable cannabis traits and strains is creating a positive outlook for the market. Other factors, including rising consumer awareness regarding the importance of the safety and quality of cannabis products, increasing investment in the research and development (R&D) of innovative testing devices, and the incorporation of advanced technologies, such as blockchain and artificial intelligence (AI), are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 2,619 Million by 2028, exhibiting a CAGR of 13.00% during 2023-2028.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).